A KAIST team presented a highly customizable neural stimulation method. The research team developed a technology that can print the heat pattern on a micron scale to enable the control of biological activities remotely.
The researchers integrated a precision inkjet printing technology with bio-functional thermo-plasmonic nanoparticles to achieve a ‘selective nano-photothermal neural stimulation method.’
The research team of Professor Yoonkey Nam at the Department of Bio and Brain Engineering expects this will serve as an enabling technology for personalized precision neuromodulation therapy for patients with neurological disorders.
The nano-photothermal neural stimulation method uses the thermo-plasmonic effect of metal nanoparticles to modulate the activities of neuronal networks. With the thermo-plasmonic effect, metal nanoparticles can absorb specific wavelength of illuminated light to efficiently generate localized heat. The research team discovered the inhibitory behavior of spontaneous activities of neurons upon photothermal stimulation four years ago. Since then, they have developed this technology to control hyperactive behaviors of neurons and neural circuits, which is often found in neurological disorders such as epilepsy.
In order to overcome the limitation on the spatial selectivity and resolution of the previously developed nano-photothermal method, the team adopted an inkjet printing technology to micro pattern the plasmonic nanoparticles (a few tens of microns), and successfully demonstrated that the nano-photothermal stimulation can be selectively applied according to the printed patterns.
The researchers applied a polyelectrolyte layer-by-layer coating method to printing substrates in a way to improve the pattern fidelity and achieve the uniform assembly of nanoparticles. The electrostatic attraction between the printed nanoparticles and the coated printing substrate also helped the stability of the attached nanoparticles. Because the polyelectrolyte coating is biocompatible, biological experiments including cell culture are possible with the technology developed in this work.
Using printed gold nanorod particles in a few tens of microns resolution over a several centimeters area, the researchers showed that highly complex heat patterns can be precisely formed upon light illumination according to the printing image.
Lastly, the team confirmed that the printed heat patterns can selectively and instantaneously inhibit the activities of cultured hippocampal neurons upon near-infrared light illumination. Because the printing process is applicable to thin and flexible substrates, the technology can be easily applied to implantable neurological disorder treatment devices and wearable devices. By selectively applying the heat patterns to only the desired cellular areas, customized and personalized photothermal neuromodulation therapy can be applied to patients.
“The fact that any desired heat patterns can be simply ‘printed’ anywhere broadens the applicability of this technology in many engineering fields. In bioengineering, it can be applied to neural interfaces using light and heat to modulate physiological functions. As another engineering application, for example, printed heat patterns can be used as a new concept of anti-counterfeit applications,” said the principal investigator, Yoonkey Nam at KAIST.
Learn more: Printed Thermo-Plasmonic Heat Patterns for Neurological Disorder Treatment
The Latest on: Nano-photothermal neural stimulation
[google_news title=”” keyword=”nano-photothermal neural stimulation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Nano-photothermal neural stimulation
- Colorectal cancer is increasing among young people. It’s time to boost research on iton May 1, 2024 at 1:30 am
Despite its devastating impact, colorectal cancer is the only top-five cancer killer without its own research program within the Department of Defense's Congressionally Directed Medical Research ...
- King Charles' 'sausage fingers' back in the spotlight as he returns to work after cancer diagnosison April 30, 2024 at 9:06 pm
King Charles has returned to his Royal engagements after a brief hiatus due to his cancer diagnosis and treatment. As he steps back into the limelight, attention is once again drawn to his notably ...
- What happens after a cancer diagnosis? 3 things to be aware ofon April 30, 2024 at 9:00 pm
“Cancer is a very emotional term in our society, and for good reason,” said Dr. Ruben Mesa, the president of Atrium Health Levine Cancer and the executive director of Atrium Health Wake Forest Baptist ...
- King Charles Calls Cancer Diagnosis a “Bit of a Shock”on April 30, 2024 at 1:09 pm
King Charles met with patients and staff at Macmillan Cancer Centre at University College Hospital before undergoing treatment for his own illness.
- King Charles Holds Hands With Cancer Patients in First Public Outing Since His Own Diagnosison April 30, 2024 at 9:23 am
The 75-year-old monarch, who revealed his diagnosis in February, opted for a cause close to home to mark his return to work.
- King Charles returns to public duties after cancer diagnosison April 30, 2024 at 7:44 am
King Charles returned to public duties for the first time in three months since announcing his cancer diagnosis by visiting a cancer treatment charity. NBC News’ royal commentator Daisy McAndrew talks ...
- King Charles visits cancer center as monarch returns to public duties following diagnosison April 30, 2024 at 5:53 am
King Charles III was diagnosed with a form of cancer and is undergoing treatment, Buckingham Palace announced in February. The monarch suspended public engagements.
- King Charles Returns to Royal Duties in First Official Engagement Since Cancer Diagnosison April 30, 2024 at 5:04 am
Queen Camilla joined him for his visit to a London hospital's cancer unit. King Charles is back. On April 30, the monarch made his return to royal duties with his first official engagement since ...
- Womb cancer symptoms to look out for after EastEnders star Cheryl Fergison opens up about diagnosison April 30, 2024 at 4:49 am
Soap fans were left in shock after Cheryl Fergison revealed that she'd been diagnosed with womb cancer back in 2015. The 58-year-old actor, who played Heather Trott on EastEnders for five years, ...
via Bing News